Kyverna Therapeutics Target Price

Where could KYTX trade next? Consensus target price: $25.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.25

Average Target Price

$25.00

203% upside

1 analysts in the last 4 months

High: $25 | Low: $25

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-15	H.C. WainwrightMitchell Kapoor	$25	203% upside
2025-12-16	Wells Fargo	$33	300% upside
2025-12-15	UBS	$32	287.9% upside
2025-12-15	Morgan StanleyMichael Ulz	$33	300% upside
2025-12-04	Morgan StanleyMichael Ulz	$25	203% upside
2025-10-27	H.C. Wainwright	$20	142.4% upside
2025-08-29	H.C. Wainwright	$10	21.2% upside

Kyverna Therapeutics (KYTX) FAQ

Kyverna Therapeutics's target price stands at $25. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $25 for KYTX implies 203.0% upside versus today's price ($8.25). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Kyverna Therapeutics's target price evolved across reporting periods, while the comparison chart places KYTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.